AVZIVI
LIVE

Serial Number

79345700

Owner

Novartis AG

Filing Date

Apr 13, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AVZIVI Trademark

Serial Number: 79345700 • Registration: 6959624

AVZIVI is a trademark filed by Novartis AG on April 13, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (17 trademarks)

CH-4002 Basel

Entity Type: 03

Sandoz AG (9 trademarks)

Viaduktstrasse 3

Entity Type: 03

Trademark Details

Filing Date

April 13, 2022

Registration Date

January 24, 2023

Published for Opposition

November 8, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 3, 2026 NREP
CHANGE OF OWNER RECEIVED FROM IB
Jan 19, 2024 CHLD
NOTIFICATION PROCESSED BY IB
Apr 4, 2023 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Mar 16, 2023 FICS
FINAL DISPOSITION PROCESSED
Mar 16, 2023 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 23, 2023 GPAR
REGISTERED-PRINCIPAL REGISTER
Jan 24, 2023 R.PR
PUBLISHED FOR OPPOSITION
Nov 8, 2022 PUBO
NOTICE OF PUBLICATION
Oct 19, 2022 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 3, 2022 CNSA
ASSIGNED TO EXAMINER
Oct 3, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 30, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 26, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 25, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 21, 2022 REPR